Skip to content

Clinical trials

Glomerulonephritis, IGA trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Country / region: Canada Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20182
20192
20203
20213
20223
20232
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting6
Recruiting4
Terminated4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Otsuka Pharmaceutical Development & Commercialization, Inc.4
Alexion Pharmaceuticals, Inc.2
Calliditas Therapeutics AB2
The George Institute2
Alnylam Pharmaceuticals1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Biogen1
Hoffmann-La Roche1
Ionis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA22
Glomerulonephritis8
Renal Insufficiency, Chronic6
Kidney Diseases5
Proteinuria5
Urologic Diseases3
Autoimmune Diseases2
Immune System Diseases2
Kidney Failure, Chronic2
Nephritis2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.